Southern Research Institute

Cro services provides drug discovery and pre-clinical drug development to pharmaceutical and biotechnology on an outsourced basis. Southern research institute has capabilities in all phases of the early-stage drug discovery and development process and provides clients with comprehensive services and support to assist them in streamlining their custom drug discovery and development programs. Some of southern research institute's significant pre-clinical research accomplishments include: demonstrated the efficacy of combination chemotherapy in mice, leading the way for the development of therapeutic approaches with improved clinical outcomes in certain cancers, performed pre-clinical drug development evaluations and analyses on approximately half of the fda-approved cancer therapeutics currently on the market, and contributed to the development of the first drug delivery technology for the extended release of synthetic agents that promote the treatment of prostate cancer.

Southern research's stem education outreach program is involved in a wide variety of programs that impact students and teachers in alabama. The mission of sr's stem program is to enhance 6th through 12th grade stem education by drawing upon the expertise and scholarly contributions of the southern research community. We aim to define and exemplify effective stem education to maximize students' readiness to excel in a rapidly changing world. We are working to achieve our education mission by engaging students and teachers in stem activities through summer learning programs, field trips, after-school programing, stem competitions and science fairs, internships, and professional development workshops for stem educators. Our primary objective is to embolden students who possess a passion for innovation and discovery to pursue their interests and strengthen the stem community. Southern research is committed to fostering creativity and impacting the future generation.

Catalyst by southern research is a unique public health data system that connects patient genomes (and other forms of personalized medical data, potentially including transcriptomics, proteomics, metabolomics and others) to clinical data to support the health of communities. Sr will accomplish this goal by investing infrastructure to (a) expand access to personalized medicine in alabama, especially in underserved areas of the state; (b) ensure alabamians have more effective diagnostics data to identify and treat underlying conditions and undetected co-morbidities that proved fatal for many alabamians during the covid-19 pandemic; and (c) enable greater access to clinical trials throughout the state. The catalyst program is designed to enhance and provide additioanl preventative care options to alabamians by (1) empowering individual with knowledge about their health; (2) connecting clinical and genomic data with local healthcare providers; and (3) encouraging participation in promising research via targeted clinical trials.